SciSparc (SPRC) Interest & Investment Income (2018 - 2022)

SciSparc (SPRC) posted Interest & Investment Income of $468000.0 for Q4 2018, up 7.09% sequentially from $437000.0 in Q2 2018.

SciSparc (SPRC) Interest & Investment Income (2018 - 2022) Analysis & Trends

SciSparc has reported Interest & Investment Income for 1 years, with the latest figure at $468000.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	48.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	67.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	27.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	28.14 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	115.94 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	10.98 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	5.13 Mn
10	SciSparc	831,418.60	831,418.60	-	-

Download Data